GCM
MEDP icon

Gallacher Capital Management’s Medpace MEDP Stock Holding History

Gallacher Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$326K Buy
615
+32
+5% +$14.8K 0.18% 185
2026
Q1 		$280K Buy
583
+51
+10% +$26.1K 0.11% 231
2025
Q4 		$299K Buy
532
+6
+1% +$3.41K 0.12% 233
2025
Q3 		$270K Sell
526
-738
-58% -$322K 0.11% 256
2025
Q2 		$397K Buy
1,264
+9
+0.7% +$2.7K 0.18% 168
2025
Q1 		$382K Sell
1,255
-278
-18% -$93.5K 0.19% 159
2024
Q4 		$509K Sell
1,533
-201
-12% -$68.2K 0.25% 88
2024
Q3 		$579K Buy
1,734
+1,192
+220% +$453K 0.27% 80
2024
Q2 		$223K Sell
542
-549
-50% -$217K 0.12% 232
2024
Q1 		$441K Sell
1,091
-47
-4% -$16.5K 0.22% 105
2023
Q4 		$349K Sell
1,138
-250
-18% -$67.5K 0.19% 137
2023
Q3 		$336K Sell
1,388
-119
-8% -$30.4K 0.21% 119
2023
Q2 		$362K Buy
+1,507
New +$313K 0.21% 133
2023
Q1 		– Sell
-1,104
Closed -$235K – 261
2022
Q4 		$235K Buy
+1,104
New +$221K 0.14% 187

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Gallacher Capital Management's MEDP Position: Q2 2026 in Review

Gallacher Capital Management increased its Medpace (MEDP) stake by 5.5% in Q2 2026, buying an estimated $14.8K and bringing the position to 615 shares worth $326K. The position accounts for 0.18% of the portfolio, ranked #185.

Gallacher Capital Management first reported a position in MEDP in Q4 2022 and has held it in 14 quarters since. The position peaked at $579K in Q3 2024. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Gallacher Capital Management held 615 shares of Medpace worth $326K as of Q2 2026.
  • Gallacher Capital Management bought 32 Medpace shares in Q2 2026, an estimated $14.8K.
  • Medpace made up 0.18% of Gallacher Capital Management's portfolio in Q2 2026, its #185 holding.
  • Gallacher Capital Management first reported a position in Medpace in Q4 2022 and has held it in 14 quarters since.
  • Gallacher Capital Management's Medpace position peaked at $579K in Q3 2024.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.